Streetbeat News

Analyst Ratings

HOLX

Needham analyst Mike Matson has maintained a 'Buy' rating on Hologic (NASDAQ:HOLX) but lowered the price target from $95 to $83.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:40 am

TNET

Needham analyst Kyle Peterson has reiterated a 'Buy' rating on Trinet Group (NYSE:TNET) and maintained a price target of $135.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:38 am

WKME

Needham analyst Scott Berg has reiterated a 'Buy' rating on WalkMe (NASDAQ:WKME) and maintained a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:35 am

CNMD

Needham analyst Mike Matson has maintained a 'Buy' rating on Conmed (NYSE:CNMD) but lowered the price target from $140 to $119.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:33 am

ETD

Telsey Advisory Group analyst Joseph Feldman maintains a 'Market Perform' rating on Ethan Allen Interiors (NYSE:ETD) and lowers the price target from $33 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:22 am

FIGS

Telsey Advisory Group has reiterated its 'Outperform' rating on FIGS (NYSE:FIGS) and maintained its price target of $11.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:16 am

EL

Telsey Advisory Group has reiterated its 'Outperform' rating on Estee Lauder Cos (NYSE:EL) and maintained its price target of $210.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:13 am

PCOR

BMO Capital analyst Daniel Jester has initiated coverage on Procore Technologies (NYSE:PCOR) with an Outperform rating and a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:11 am

MXL

Roth MKM analyst Suji Desilva has downgraded MaxLinear (NASDAQ:MXL) from Buy to Neutral and lowered the price target from $35 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:09 am

CNTA

Morgan Stanley analyst Matthew Harrison has upgraded Centessa Pharmaceuticals (NASDAQ:CNTA) from Underweight to Equal-Weight and raised the price target from $4 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 9:07 am